Pharmac has announced the decision for a Preferred Brand model when funding Haemophilia A treatment. You can acess the full decision and read some commentary from Pharmac here:
http://www.pharmac.health.nz/news/notification-2015-07-06-haemophilia-treatments/
As stated in the commentary the Haemophilia Foundation will be working with Pharmac and the newly established Haemophilia Treatments Panel as well as the NZ Treaters Group on how to best support people with Haemophilia who are required to change product.
